Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol
赞助:
Assisting Nature
合作者:
信息的提供 (责任方):
Papanikolaou Evaggelos,Assisting Nature
追踪信息 | |||
---|---|---|---|
首次提交日期 ICMJE | September 24, 2018 | ||
首次发布日期e ICMJE | October 3, 2018 | ||
最后更新发布日期 | October 3, 2018 | ||
预计研究开始日期 ICMJE | January 12, 2017 | ||
预计主要完成日期 | August 31, 2019 (主要结果测量的最终数据收集日期) | ||
目前主要观察指标 ICMJE |
Clinical Pregnancy Rate according to stimulation protocol[ Time Frame: 6 weeks to 42 weeks after embryo transfer ] Clinical Pregnancy Rate according to stimulation protocol Number of formed blastocysts in each group of patients[ Time Frame: 5 days after the OPU day ] The number of the formed blastocysts in each group of patients according to the COS protocol |
||
原始主要观察测量 ICMJE | 与当前相同 | ||
目前的二级观察 ICMJE |
|
||
描述性信息 | |||
简略标题 ICMJE | Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol | ||
正式标题 ICMJE | Clinical and Live Birth Rates After Controlled Ovarian Stimulation With the Long Antagonist Protocol Versus the Long Agonist Protocol | ||
简要概况 | A prospective study of the evaluation of the clinical IVF (in vitro fertilization) results after following Long Antagonist protocol for Controlled Ovarian Stimulation (COS) versus following Long Agonist protocol |
||
详细说明 | A prospective study of the clinical results in women who followed the Long Antagonist protocol for Controlled Ovarian Stimulation (COS) versus women who followed Long Agonist protocol, in an In Vitro Fertilization (IVF) try. In particular, the Clinical Pregnancy Rates (CPR) and Live Birth Rates (LBR) were estimated for the two groups of patients. The number of the formed blastocysts was also measured in each group of patients. | ||
研究类型 ICMJE | Observational | ||
研究阶段 | |||
研究设计 ICMJE | 分配: 干预模型: 干预模型描述: 盲法: Observational 盲法描述: 主要目的: |
||
适用条件 ICMJE | |||
干预项目 ICMJE |
|
||
研究工具 |
|
||
招募信息 | |||
招募状态 ICMJE | Recruiting | ||
预计入组 ICMJE |
120 | ||
原始预计入组 ICMJE | 与当前相同 | ||
预计研究完成日期 | August 31, 2019 | ||
预计主要完成日期 | August 31, 2019 (主要结果测量的最终数据收集日期) | ||
合格标准 ICMJE | Inclusion Criteria: - primary infertility - age 18-39 years; body mass index (BMI) 18-29kg/m2; - regular menstrual cycle of 26-35days, - presumed to be ovulatory; - early follicular- phase serum concentration of FSH within normal limits (1-12 IU/l). Exclusion Criteria: - women with diabetes and other metabolic disease - women with heart disease, QT prolongation,heart failure - elevated liver enzymes, liver failure, hepatitis - women with inflammatory or autoimmune disease - abnormal karyotype; - polycystic ovarian syndrome, - endometriosis stage III/IV; - history of being a 'poor responder', - defined as >20 days of gonadotrophin in a previous stimulation cycle, or any previous cancellation of a stimulation cycle due to limited follicular response, or development of less than 4 follicles 15 mm in a previous stimulation cycle; history of recurrent miscarriage; severe OHSS in a previous stimula- tion cycle or any contraindication for the use of gonadotrophins. | ||
性别 |
|
||
年龄 | 最小年龄:18 Years ,最大年龄:39 Years | ||
接受健康的志愿者 | 没有 | ||
可入组国家 ICMJE | Greece | ||
管理信息 | 数据检测委员会 | Yes | |
研究涉及美国FDA监管的产品 |
研究美国FDA监管的药品: No 研究涉及美国FDA监管的设备产品: No |
||
IPD 共享声明 |
|
||
责任方 | Papanikolaou Evaggelos,Assisting Nature | ||
研究赞助商 ICMJE | Assisting Nature | ||
合作者 ICMJE | |||
研究员 ICMJE |
|
||
PRS 账户 | Assisting Nature | ||
验证日期 | October 2018 | ||
ICMJE 国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素 |
请使用微信扫码报名